Formats
  1. Journal Article (66894)
  2. Meeting Abstract (33621)
  3. Book Section (5097)
  4. Review (3749)
  5. Editorial (2165)
  6. Conference Paper (1526)
  7. Correspondence (663)
  8. Guidelines (661)
  9. Research Letter (548)
  10. Book Whole (344)
  11. Miscellaneous (339)
Groups
  1. Department of Medicine (39043)
  2. GSK Faculty (22462)
  3. Solid Tumor Oncology Division (22061)
  4. Surgery (21262)
  5. Survivorship Research (15766)
  6. Sloan Kettering Institute Faculty (15652)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1050)

More People

Years
  1. 2025 (2139)
  2. 2024 (5384)
  3. 2023 (5806)
  4. 2022 (6169)
  5. 2021 (5714)
  6. 2020 (5618)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4951)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2611)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1814)

More Publications

Publishers
  1. Elsevier Inc. (13846)
  2. American Society of Clinical Oncology (9169)
  3. Springer (7192)
  4. Nature Publishing Group (6375)
  5. American Association for Cancer Research (6014)
  6. Elsevier Science, Inc. (5512)

More Publishers

Results (115607)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 2 multicohort study of CC-90011, a LSD1 inhibitor, in combination with nivolumab in patients with advanced lung cancer
    Meeting Abstract

    Rudin, C. M.; Navarro, A.; Carcereny, E.; Villaruz, L. C.; Lo Russo, G.; Ricordel, C.; Bearz, A.; Li, J.; Elias, I.; Bhingare, A.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Microsatellite instability defines a subset of lung cancers with smoking exposure, high tumor mutational burden and MLH1 inactivation
    Meeting Abstract

    Yang, S. R.; Gedvilaite, E.; Ptashkin, R.; Chang, J.; Ziegler, J.; Mata, D.; Villafania, L. B.; Nafa, K.; Hechtman, J. F.; Benhamida, J.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Predictive biomarkers of response to REGN5093 to guide patient selection in MET-altered advanced non-small cell lung cancer
    Meeting Abstract

    Navas, T.; Drilon, A. E.; Cho, B. C.; Viau, J.; Tao, W.; Zhu, Y. O.; Giangreco, N.; Perez, J.; Masinde, S.; Paccaly, A.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Identifying early and late hallmarks of plasticity in neuroendocrine transformation of lung cancer at single-cell level
    Meeting Abstract

    Chan, J. M.; Quintanal-Villalonga, A.; Sabet, A.; Manoj, P.; Masilionis, I.; Falcon, C.; Sohail, N.; Chun, J.; Nawy, T.; Mazutis, L.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • KRYSTAL-1: Two-year follow-up of adagrasib (MRTX849) monotherapy in patients with advanced/metastatic KRASG12C-mutated NSCLC
    Meeting Abstract

    Gadgeel, S.; Jänne, P. A.; Spira, A. I.; Ou, S. H. I.; Heist, R. S.; Pacheco, J. M.; Johnson, M. L.; Sabari, J. K.; Leventakos, K.; Mason, J. A.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • CodeBreaK 101: Safety and efficacy of sotorasib with carboplatin and pemetrexed in KRAS G12C-mutated advanced NSCLC
    Meeting Abstract

    Clarke, J. M.; Felip, E.; Li, B. T.; Ruffinelli, J. C.; Garrido, P.; Zugazagoitia, J.; Goldberg, S. B.; Ramalingam, S. S.; Victoria, I.; Puri, S.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Real-world landscape analysis of activating ERBB2/ERBB3 alterations in 107,561 tissue and plasma samples from patients with NSCLC
    Meeting Abstract

    Liu, D.; Jee, J.; Keller, R. B.; Schrock, A. B.; Drilon, A.; Oxnard, G. R.; Li, B. T.
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Initial chemotherapy for locally advanced and metastatic NUT carcinoma
    Meeting Abstract

    Luo, J.; Finstein, B.; Sanchez, M.; Lee, E.; Hertzler, H.; Luong, N.; Tamen, R.; Brisbane, G.; Nguyen, T.; Paik, P. K.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • An analysis of the rate of second primary lung cancer from CALGB (Alliance) 140503 trial of lobar versus sub-lobar resection for T1aN0 NSCLC
    Meeting Abstract

    Stinchcombe, T. E.; Wang, X.; Damman, B.; Mentlick, J.; Landreneau, R.; Wigle, D.; Jones, D. R.; Conti, M.; Ashrafi, A. S.; Liberman, M.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Three-year outcomes with first-line pembrolizumab, in patients with non-small-cell lung cancer and a PD-L1 tumor proportion score >90%
    Meeting Abstract

    Ricciuti, B.; Arielle Elkrief, A.; Lin, J.; Altan, M.; Alessi, J.; Gandhi, M.; Pecci, F.; Lamberti, G.; Di Federico, A.; Wang, X.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save